Figure 2
Figure 2. Kaplan-Meier survival analysis based on numbers of cells positive by immunohistochemistry for each of the antibodies assayed. The data for each antibody were initially grouped into 4 quartiles for use in Kaplan-Meier survival analysis, shown for (A) CD3, (C) CD7, and (E) CD4: the survival curves as shown as 1 = 1st quartile, 2 = 2nd quartile, 3 = 3rd quartile & 4 = 4th quartile (1st quartile used for lower end of gene expression for each gene). Further Kaplan-Meier survival analysis was performed for CD3, CD7, and CD4, grouping the higher and lower quartiles, as shown for (B) CD3, (D) CD7, and (F) CD4. Quartile groupings used in these analyses are indicated in each panel. Kaplan-Meier survival analysis for CD68 was performed separately for cases with 15 or fewer (1) or greater than 15 macrophages (2) per high-power field, as shown in panel G.

Kaplan-Meier survival analysis based on numbers of cells positive by immunohistochemistry for each of the antibodies assayed. The data for each antibody were initially grouped into 4 quartiles for use in Kaplan-Meier survival analysis, shown for (A) CD3, (C) CD7, and (E) CD4: the survival curves as shown as 1 = 1st quartile, 2 = 2nd quartile, 3 = 3rd quartile & 4 = 4th quartile (1st quartile used for lower end of gene expression for each gene). Further Kaplan-Meier survival analysis was performed for CD3, CD7, and CD4, grouping the higher and lower quartiles, as shown for (B) CD3, (D) CD7, and (F) CD4. Quartile groupings used in these analyses are indicated in each panel. Kaplan-Meier survival analysis for CD68 was performed separately for cases with 15 or fewer (1) or greater than 15 macrophages (2) per high-power field, as shown in panel G.

Close Modal

or Create an Account

Close Modal
Close Modal